Department of Neurology, Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Department of Pharmacology, Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
J Neuroimaging. 2023 Jan;33(1):121-133. doi: 10.1111/jon.13045. Epub 2022 Sep 6.
The circuitry underlying heterogenous cognitive profiles in Parkinson's disease (PD) remains unclear. The purpose of this study is to investigate whether structural changes in frontostriatal and limbic pathways contribute to different cognitive trajectories in PD.
We obtained clinical and multimodal MRI data from 120 control and 122 PD subjects without dementia or severe motor disability. T1/T2-weighted images estimated volume, and diffusion imaging evaluated fractional anisotropy (FA) of frontostriatal (striatum and frontostriatal white matter [FSWM]) and limbic (hippocampus and fornix) structures. Montreal Cognitive Assessment (MoCA) gauged total and domain-specific (attention/executive and memory) cognitive function. Linear mixed-effects models were used to compare MRI and cognitive progression over 4.5 years between controls and PD and evaluate associations between baseline MRI and cognitive changes in PD.
At baseline, control and PD groups were comparable, except PD participants had smaller striatal volume (p < 0.001). Longitudinally, PD showed faster decline in hippocampal volume, FSWM FA, and fornix FA (ps < .016), but not striatal volume (p = .218). Total and domain-specific MoCA scores declined faster in PD (ps < .030). In PD, lower baseline hippocampal volume (p = .005) and fornix FA (p = .032), but not striatal volume (p = .662) or FSWM FA (p = .143), were associated with faster total MoCA decline. Baseline frontostriatal metrics of striatal volume and FSWM FA were associated with faster attention/executive decline (p < .038), whereas lower baseline hippocampal volume was associated with faster memory decline (p = .005).
In PD, frontostriatal structural metrics are associated with attention/executive tasks, whereas limbic changes correlated with faster global cognitive decline, particularly in memory tasks.
帕金森病(PD)认知表现异质性的潜在机制尚不清楚。本研究旨在探讨额纹状体和边缘通路的结构变化是否与 PD 不同的认知轨迹有关。
我们从 120 名无痴呆或严重运动障碍的对照组和 122 名 PD 患者中获得了临床和多模态 MRI 数据。T1/T2 加权图像估计体积,弥散成像评估额纹状体(纹状体和额纹状体白质[FSWM])和边缘(海马和穹窿)结构的分数各向异性(FA)。蒙特利尔认知评估(MoCA)评估了总认知功能和特定领域(注意力/执行和记忆)认知功能。线性混合效应模型用于比较 4.5 年期间对照组和 PD 患者的 MRI 和认知进展,并评估 PD 患者基线 MRI 与认知变化之间的相关性。
在基线时,对照组和 PD 组之间没有差异,除了 PD 患者的纹状体体积较小(p<0.001)。纵向来看,PD 患者的海马体积、FSWM FA 和穹窿 FA 下降更快(p<0.016),而纹状体体积下降较慢(p=0.218)。总 MoCA 和特定领域(注意力/执行和记忆)的评分在 PD 中下降更快(p<0.030)。在 PD 中,较低的基线海马体积(p=0.005)和穹窿 FA(p=0.032),但不是纹状体体积(p=0.662)或 FSWM FA(p=0.143),与总 MoCA 下降更快相关。基线额纹状体结构的纹状体体积和 FSWM FA 与注意力/执行任务相关,而较低的基线海马体积与记忆任务的更快下降相关。
在 PD 中,额纹状体结构指标与注意力/执行任务相关,而边缘变化与整体认知下降较快相关,尤其是在记忆任务中。